New drug combo aims to save bladders from cancer surgery
Disease control
Recruiting now
This study is testing a combination of two immunotherapy drugs, durvalumab and monalizumab, for people with early-stage bladder cancer that has not responded well to the standard BCG treatment. The goal is to see if this drug combination can eliminate the cancer and help patients…
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC